We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVST icon
1051
Envista
NVST
$4.36B
$309K ﹤0.01%
18,589
-1,474
-7% -$27.9K
WMG icon
1052
Warner Music
WMG
$14.7B
$308K ﹤0.01%
+10,059
New +$323K
TMDX icon
1053
Transmedics
TMDX
$3.06B
$306K ﹤0.01%
+2,031
New +$244K
MATX icon
1054
Matsons
MATX
$6.71B
$306K ﹤0.01%
2,334
+71
+3% +$8.25K
WOLF icon
1055
Wolfspeed
WOLF
$1.34B
$305K ﹤0.01%
13,419
-1,301
-9% -$33.6K
MOG.A icon
1056
Moog Inc Class A
MOG.A
$11.9B
$302K ﹤0.01%
1,807
+52
+3% +$8.55K
AVAV icon
1057
AeroVironment
AVAV
$7.52B
$302K ﹤0.01%
1,659
+20
+1% +$3.6K
ADNT icon
1058
Adient
ADNT
$1.47B
$302K ﹤0.01%
12,225
-2,930
-19% -$83.2K
HLNE icon
1059
Hamilton Lane
HLNE
$4.6B
$301K ﹤0.01%
2,435
+211
+9% +$24.7K
FORM icon
1060
FormFactor
FORM
$7.93B
$298K ﹤0.01%
4,925
+241
+5% +$12.6K
HELE icon
1061
Helen of Troy
HELE
$666M
$298K ﹤0.01%
3,210
-218
-6% -$22.1K
BFH icon
1062
Bread Financial
BFH
$4.06B
$296K ﹤0.01%
+6,646
New +$261K
ABG icon
1063
Asbury Automotive
ABG
$3.8B
$296K ﹤0.01%
1,297
+32
+3% +$7.26K
TDW icon
1064
Tidewater
TDW
$4.61B
$294K ﹤0.01%
3,092
+279
+10% +$27.5K
SMG icon
1065
ScottsMiracle-Gro
SMG
$3.52B
$294K ﹤0.01%
4,521
-4,228
-48% -$289K
BHF icon
1066
Brighthouse Financial
BHF
$3.05B
$293K ﹤0.01%
6,770
-1,394
-17% -$64.3K
ACLS icon
1067
Axcelis
ACLS
$3.56B
$293K ﹤0.01%
2,061
+92
+5% +$10.6K
KRYS icon
1068
Krystal Biotech
KRYS
$10.4B
$290K ﹤0.01%
1,577
+265
+20% +$44.5K
BROS icon
1069
Dutch Bros
BROS
$6.88B
$289K ﹤0.01%
+6,973
New +$240K
ITRI icon
1070
Itron
ITRI
$4.27B
$288K ﹤0.01%
2,910
+142
+5% +$14.3K
VRRM icon
1071
Verra Mobility
VRRM
$669M
$287K ﹤0.01%
10,535
+2,212
+27% +$57.1K
COLM icon
1072
Columbia Sportswear
COLM
$2.97B
$285K ﹤0.01%
3,599
-529
-13% -$42.8K
SUM
1073
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$281K ﹤0.01%
7,687
+448
+6% +$17.6K
AL
1074
DELISTED
Air Lease Corp
AL
$281K ﹤0.01%
5,919
+55
+0.9% +$2.67K
CAR icon
1075
Avis
CAR
$4.88B
$280K ﹤0.01%
2,681
-182
-6% -$20.4K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.